SensoDetect participates in Biostock Event in Stockholm on 27 November

SensoDetects CEO Johan Olsson will make a presentation during the Biostocks Event in Stockholm on 27 November. This presentation will be in English and broadcasted both in Europe and North America via Biostocks partners. The presentation will focus on SensoDetects unique technology and planned launch.


SensoDetect works with a new unique technology that gets more attention around the world and CEO Johan Olsson has therefore participated in several events both in Sweden and Denmark recently so the possibility of Biostock event and their dispersal outside the home region makes the presentation a little special. The presentation will be held in English and some other material will also now be subtitled in English so that potential investors, customers and other interested parties can follow SensoDetect. Presentation will be broadcasted by the news agency Direct (live) and Endpoint News (Delayed for adaptation to North american time). 

Biostock is a news and analysis service that presents Nordic listed companies within Life Science directed to individuals, organisations and companies. More info about Biostock available on their website; www.biostock.se

"It is always exciting to have the opportunity to present our company and the progress we made and disseminate info about the upcoming launch that we see ahead of us shortly. Then it is particularly interesting in this case when the presentation will be held in English as it will be broadcasted far outside Sweden which opens up for new and exciting opportunities as I see it and we want to absolutely take advantage an oppertunity like this!", says CEO , Johan Olsson, SensoDetect AB (Publ.)

Johan OlsonCEO, SensoDetect Aktiebolag (publ)

Phone: +46 705 424600

e-mail: jo@sensodetect.com

 

SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.

Our Mission
Improve the lives of people with mental illness
Our Vision
Making ABR profiling tests with SensoDetect technology an integral part of setting diagnosis for mental illness
Our Value Proposition:
SensoDetect provides a complete audiogram for the brainstem, helping health care professional to set psychiatric diagnoses objectively and
cost effectively. This unique offering improves patients’ quality of life and reduces the economic impact on the health care system and society

Subscribe

Documents & Links

Quotes

It is always exciting to have the opportunity to present our company and the progress we made and disseminate info about the upcoming launch that we see ahead of us shortly. Then it is particularly interesting in this case when the presentation will be held in English as it will be broadcasted far outside Sweden which opens up for new and exciting opportunities as I see it and we want to absolutely take advantage an oppertunity like this!
CEO, Johan Olsson, SensoDetect AB (publ.)